Patient Leaflet Updated 04-Dec-2025 | Baxter Healthcare Ltd
Ondansetron 2mg/ml Solution for Injection
ONDANSETRON 2 mg/ml SOLUTION FOR INJECTION
Ondansetron (as hydrochloride dihydrate)
The name of your medicine is Ondansetron 2 mg/ml Solution for Injection, which will be called Ondansetron Injection or Ondansetron throughout this leaflet.
1. What Ondansetron Injection is and what it is used for
2. What you need to know before you have Ondansetron Injection
3. How to have Ondansetron Injection
4. Possible side effects
5. How to store Ondansetron Injection
6. Contents of the pack and other information
Ondansetron Injection is a clear solution containing the active ingredient ondansetron, which is an anti-emetic (prevents nausea [feeling sick] and vomiting).
Ondansetron Injection is used for:
Ask your doctor, pharmacist or nurse if you would like any further explanation about these uses.
If you are not sure, talk to your doctor, nurse or pharmacist before having Ondansetron injection.
Check with your doctor, pharmacist or nurse before having Ondansetron injection if:
If you are not sure if any of the above apply to you, talk to your doctor, nurse or pharmacist before having Ondansetron injection.
Please tell your doctor, pharmacist or nurse if you are taking , or have recently taken, or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because ondansetron injection can affect the way some medicines work. Also some other medicines can affect the way ondansetron injection works.
In particular, tell your doctor, pharmacist or nurse if you are taking any of the following medicines:
If you are not sure if any of the above applies to you, talk to your doctor, nurse or pharmacist before having Ondansetron injection.
Ondansetron injection should not be given in the same syringe or infusion (drip) as any other medication.
Only use during the first trimester of pregnancy after discussion with your doctor of the potential benefits and risks to you and your unborn baby of the different treatment options. This is because Ondansetron injection can slightly increase the risk of a baby being born with cleft lip and/or cleft palate (openings or splits in the upper lip and/or the roof of the mouth). If you are already pregnant, think you are might be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before having ondansetron injection. If you are a woman of childbearing potential you may be advised to use effective contraception.
Do not breast-feed if you have ondansetron injection. This is because small amounts pass into mother's milk, Ask your doctor or midwife for advice.
Ondansetron Injection has no effect on your ability to drive or use machines.
Ondansetron injection contains Sodium citrate and sodium chloride.
This product contains 3.6mg/ml of sodium. Ondansetron contains 2.52 mmol (57.6 mg) sodium per maximum daily dose of 32 mg.
To be taken into consideration by patients on a controlled sodium diet.
Ondansetron injection is normally given by a doctor or nurse. The dose you have been prescribed will depend on the treatment you are having.
On the day of chemotherapy or radiotherapy
On the following days
If your chemotherapy or radiotherapy is likely to cause severe nausea and vomiting, you may be given more than the usual dose of Ondansetron injection. Your doctor will decide this.
The doctor will decide the dose depending on the child's size (body surface area) or weight. Look at the label for more information
On the day of chemotherapy
the first dose is given by an injection into the vein, just before your child's treatment. After chemotherapy, your child's medicine will usually be given by mouth twelve hours later, as ondansetron syrup or an ondansetron tablet.
On the following days
Adult:
Children:
The total daily dose should not be more than 8 mg.
Ondansetron injection should start to work soon after having the injection. If you continue to be sick or feel sick, tell your doctor or nurse.
Your doctor or nurse will give you or your child Ondansetron injection so it is unlikely that you or your child will receive too much. If you think you or your child have been given too much or have missed a dose, tell your doctor or nurse.
Like all medicines, ondansetron injection can cause side effects, although not everybody gets them.
If you develop any of the following side effects, tell your doctor immediately:
The following side effects have been reported:
Allergic reactions
If you have an allergic reaction, tell your doctor or a member of the medical staff straight away. The signs may include:
Myocardial ischemia
Signs include:
Very common (may affect more than 1 in 10 people)
headache.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
If you get any side effects, talk to your doctor or, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
The active substance in Ondansetron Injection is ondansetron (as hydrochloride dihydrate). Each ml of solution for injection contains 2 mg ondansetron (as ondansetron hydrochloride dihydrate).
Each glass ampoule of 2ml contains 4mg ondansetron (as hydrochloride dihydrate).
Each glass ampoule of 5ml (containing 4 ml of solution) contains 8mg ondansetron (as hydrochloride dihydrate).
The other ingredients are citric acid monohydrate, sodium citrate, sodium chloride and water for injections
Ondansetron Injection is clear, colourless solution and it comes in clear colourless glass ampoules of 2ml containing 2 ml of solution and 5 ml containing 4 ml of solution..
2 ml ampoule containing 4mg/2ml of solution.
5 ml ampoule containing 8mg/4ml of solution.
Each pack contains 25 ampoules of 2 ml or 5ml capacity glass ampoule.
Each pack contains 5 ampoules of 2 ml or 5ml capacity glass ampoule
Not all pack sizes may be marketed
This medicinal product is authorized in the Member States of EEA under the following name:
Ondansetron 2mg/ml Solution for Injection – UK, Ireland.
Ondansetron – Germany, Luxembourg.
Ondansetron Baxter – Portugal.
Ondansetron Baxter – Estonia, Latvia, Lithuania, Poland.
Ondansetron Baxter 2mg/ml oplossing voor injectie – Netherlands
Ondansetron Baxter 4mg/2 ml raztopina za injiciranje ali infundiranje – Slovenia
Ondansetron Baxter 8mg/4 ml raztopina za injiciranje ali infundiranje – Slovenia
EMISTOP – Italy
This Leaflet was last approved in 08/2025
1400008709
Caxton Way, Thetford, Norfolk, IP24 3SE, UK
0800 0260516
https://medinfo.baxterhealthcare.co.uk
https://www.baxterhealthcare.co.uk/
0800 028 9881